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Burkholderia encompass a group of ubiquitous Gram-negative bacteria that 
include numerous saprophytes, as well as several species that cause infections in animals, 
immunocompromised patients, and plants. Some species of Burkholderia produce 
colored redox-active secondary metabolites called phenazines (Phz). In the model 
opportunistic pathogen Pseudomonas aeruginosa, phenazines strongly contribute to the 
competitiveness, formation of biofilms, and virulence in multiple models of infection. 
Similar depth of knowledge on the diversity, biosynthesis, and biological functions of 
phenazines in Burkholderia is missing. This project aimed to bridge this gap in 
knowledge by focusing on phenazine pathways of B. lata and closely related species. My 
results revealed that phz genes are present in genomes of many Burkholderia that have a 
worldwide origin and belong to different species of the genus. Most Phz+ strains were in 
the Bcc group, but the capacity to synthesize phenazines was also found in some isolates 
of the B. pseudomallei clade and the plant pathogen B. glumae. My findings also suggest 
that the phenazine biosynthetic pathway of Burkholderia has a complex evolutionary 
history, which likely involved horizontal gene transfers among several distantly related 
groups of producing organisms. I also analyzed isogenic mutants and plasmid deletion 
derivatives of Burkholderia lata, which helped to identify phenazines produced by 
species of the ubiquitous B. cepacia (Bcc) group and characterize the role of phenazine-
modifying genes in the synthesis of 4,9-dihydroxyphenazine-1,6-dicarboxylic acid 
dimethylester. My functional studies failed to link the production of phenazines with the 
capacity of Burkholderia to kill fruit flies and rot onions, but other experiments revealed 
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a link between the presence and amount of phenazines and the dynamics of biofilm 
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CHAPTER I – INTRODUCTION 
1.1 Burkholderia spp. are diverse and economically important microorganisms  
Burkholderia is a ubiquitous group of Gram-negative bacteria that contain 
numerous saprophytes, as well as species that are associated with infectious diseases, 
hospital-acquired infections and necrotizing pneumonia in individuals with cystic fibrosis 
(Woods & Sokol, 2006).  These organisms were previously classified as Pseudomonas, 
but the advent of molecular and genetic techniques ultimately identified Burkholderia as 
members of a distinct genus within Betaproteobacteria (Yabuuchi et al., 1992; Estrada-de 
Los Santos et al., 2015; Eberl & Vandamme, 2016). The taxonomic status of these 
microorganisms was revised further in 2014 by dividing the group into two genera, with 
Burkholderia containing opportunistic pathogens of animal and plants, and a new genus 
Paraburkholderia harboring environmental species and nitrogen-fixing mutualists 
(Sawana, Adeolu, & Gupta, 2014). Subsequent studies established the polyphyletic nature 
of the Burkholderia and Paraburkholderia groups and separated several species into a 
new genus, Caballeronia (Dobritsa & Samadpour, 2016). There is an ongoing discussion 
about further revisions of the genus Paraburkholderia and advancing the taxonomic 
status of some species to the level of new genera.  
The genus Burkholderia encompasses over 100 species that include several 
economically important pathogens of humans, animals, and plants (Estrada-de Los Santos 
et al., 2015). Three distinct lineages are recognized within the Burkholderia sensu stricto 
group: 1) the B. pseudomallei clade of mammalian pathogens, 2) the Burkholderia 
cepacia complex (Bcc) of opportunistic pathogens, and 3) the B. glumae/B. gladioli clade 
of plant pathogens (Sawana, Adeolu, & Gupta, 2014). The B. pseudomallei clade consists 
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of closely related infectious agents that are associated with serious infections in humans 
and animals (Wiersinga et al., 2006; Whitlock, Estes, & Torres, 2007; Losada et al., 
2010). Burkholderia pseudomallei is a common soil and freshwater saprophyte, but under 
certain conditions, can infect individuals with underlying risk factors such as diabetes, 
chronic renal impairment, congestive heart failure, corticosteroid therapy, and 
malignancy (Foong, Tan, & Bradbury, 2014). This organism is a causative agent of 
melioidosis, a condition associated with nearly 20% cases of acquired septicemia in 
Southeast Asia and Northern Australia. During melioidosis, the pathogen often attacks 
lungs causing a chronic pulmonary infection but later disseminates systemically through 
the bloodstream causing life-threatening septicemia (Dance, 1991). Burkholderia 
pseudomallei is capable of intracellular motility, has multiple virulence factors (i.e., 
surface polysaccharides, type III and type VI protein secretion systems), forms biofilms 
and is intrinsically resistant to commonly used antibiotics making the successful 
treatment of melioidosis a challenge (Stone et al., 2014; Sawasdidoln et al., 2010). B. 
mallei has been traditionally considered a distinct species in the genus Burkholderia, but 
with the advent of the multi-locus sequence typing was re-classified as a subspecies of B. 
pseudomallei (Godoy et al., 2003). Unlike typical B. pseudomallei, this organism is an 
obligate mammalian pathogen with a smaller multi-replicon genome. Although primarily 
a pathogen of equines, in which B. mallei causes glanders, the bacterium is also capable 
of infecting humans through contact with diseased horses, mules, and donkeys (Van 
Zandt, Greer, & Gelhaus, 2013). The pathogen is transmitted by inhalation, via mucous 
membranes and cuts in the skin, and causes both chronic and acute infections 
accompanied by fever, pustules, abscesses, and pneumonia. If left untreated, the fatality 
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rate of B. mallei infections is as high as 95%. Due to the highly virulent nature of B. 
mallei among equine, and the ease to distribute in an aerosol form, it was used in World 
War I as biological warfare to infect the opposing force’s horses and livestock (Godoy et 
al., 2003; Wheelis, 1998). The United States Centers for Disease Control and Prevention 
(CDC) list B. pseudomallei and B. mallei among the category B priority pathogens and 
potential bioterror agents.  
The Burkholderia cepacia complex (Bcc) is named after the type species of the 
genus and includes microorganisms that are common in the environment, though under 
favorable conditions can act as opportunistic human pathogens (Sousa et al., 2011). 
Many Burkholderia spp. are typical saprophytes and particularly abundant in areas with 
acidic soils (Stopnisek et al., 2014), while others colonize eukaryotic hosts and include 
both commensals and economically important pathogens of plants and animals. Members 
of the Bcc group also include endosymbionts of insect that increase their hosts' fitness by 
protecting them from pathogens and parasites (Kim et al., 2015; Lee et al., 2017), as well 
as species that establish close associations with fungi, including arbuscular mycorrhizae, 
and benefit from the utilization of nutrients present in fungal exudates (Stopnisek et al., 
2016). Species of the Bcc complex are also well-known for the ability to catabolize 
different organic compounds as energy sources, produce an impressive array of 
secondary metabolites, and their plant growth promoting and biocontrol properties (Eberl 
& Vandamme, 2016). However, despite the tremendous biotechnological potential, the 
broader acceptance of Bcc organisms for the control of plant diseases and remediation of 
sites contaminated with recalcitrant pollutants has been hampered by the inability to 
discriminate between the beneficial environmental and the clinical strains.  
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Over the past few decades, many members of the Bcc group have emerged as 
causative agents of severe nosocomial infections in immunocompromised patients and 
individuals with cystic fibrosis (Sousa et al., 2011; Mahenthiralingam et al., 2005). 
Various strains of the B. cepacia complex have also been associated with bacteremia in 
patients with no underlying disease and identified as the cause of hospital-acquired sepsis 
in patients (Kim et al., 2016). These organisms harbor an impressive array of virulence 
determinants (i.e., type III, IV, and VI protein secretion systems, adhesins, exoproteases, 
and a lipase), some of which are regulated by homoserine lactone-producing quorum-
sensing (Loutet & Valvano, 2010). Members of the B. cepacia group also are intrinsically 
resistant to a wide range of antibiotics, form robust biofilms, and have multiple 
mechanisms to resist oxidative stress and sequester iron, making Bcc infections 
particularly challenging to treat (Sawasdidoln et al., 2010; Lewis & Torres, 2016). 
Finally, species of the B. glumae/B. gladioli clade live in association with 
different plants and colonize plant tissues externally or endophytically (Compant et al., 
2008). Many species of this group maintain commensal relationships with their hosts, but 
some act as plant pathogens. For example, B. gladioli pv. allicola causes the slippery skin 
of onions, during which the pathogen affects both the aboveground parts of the plant and 
the bulbs (Stoyanova et al., 2007). In early stages of the disease the bulbs appear healthy, 
but later the infected tissues become water-soaked and eventually decay. Interestingly, a 
similar condition known as the sour skin of onion is caused by many strains of B. 
cepacia, which can infect plants in the field or at storage and lead to the development of a 
soft, watery rot of bulbs (Stoyanova et al., 2007). Other pathovars of B. gladioli damage 
bulbs of gladioluses, irises, infect certain species of orchids (Keith, Sewake, & Zee, 
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2005), while B. gladioli pv. agaricicola produces a variety of antifungal secondary 
metabolites and is an important pathogen in the mushroom industry, where it causes a 
soft rot of button mushrooms (Agaricus bisporus) (Elshafie et al., 2016). Another serious 
emerging phytopathogen in this group is B. glumae, which is associated with the bacterial 
blight of rice. This disease was first reported in the 1950s in Japan but later spread to 
other parts of Asia, South and Central America and the United States (Ham, Melanson, & 
Rush, 2011). B. glumae secretes several phytotoxins, extracellular degradative enzymes, 
and type III secretion effectors causing in rice floret sterility, sheath rot, inhibition of seed 
germination, and seedling blight (Angus et al., 2014; Naughton et al., 2016). Although B. 
glumae and B. gladioli are typically considered plant pathogens, strains of both species 
have been isolated from immunocompromised individuals or patients with cystic fibrosis 
further highlighting the remarkable versatility of these organisms and their capacity to 
adapt and thrive in diverse environments (Devescovi et al., 2007; Martinucci et al., 
2016). 
1.2 The diversity and biosynthesis of microbial phenazines 
My project focused on strains of Burkholderia that produce the colored, redox-
active secondary metabolites called phenazines (Phz). Synthesis of phenazines is most 
common among Actinobacteria, especially Streptomyces spp., but it also occurs within 
two clades of Gram-negative bacteria (Mavrodi et al., 2006). Fluorescent Pseudomonas 
spp. are -Proteobacteria and the best-characterized phenazine producers, with strains of 
P. fluorescens, P. aureofaciens (now classified as P. chlororaphis) and P. aeruginosa 
known to synthesize these compounds. Another Phz+ gamma proteobacterium, Pantoea 
agglomerans Eh1087, belongs to the Enterobacteriaceae and synthesizes the phenazine 
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derivative D-alanylgriseoluteic acid (Giddens, Houliston, & Mahanty, 2003). Among β-
Proteobacteria, phenazines are produced by Burkholderia spp. Apart from different 
Eubacteria, the only other known phenazine producers are some archaea that employ 
membrane-embedded phenazines as electron carriers in methanogenesis (Abken et al., 
1998). 
Studies in the early 1970s in which radiolabeled compounds were added to intact 
bacterial cells identified phenazines as derivatives of the shikimic acid pathway 
(reviewed by Turner & Messenger, 1986). These experiments concluded that the 
synthesis of phenazines begins with chorismic acid, and that the phenazine tricycle is 
formed by the condensation of two chorismate molecules with glutamine used as the 
source of nitrogen in the heterocyclic nucleus. Phenazine-1,6-dicarboxylic acid (PDC) 
was proposed as the first phenazine formed, although its incorporation into the phenazine 
core could not be detected in some bacteria. Further progress towards understanding the 
reactions leading to formation of the phenazine scaffold remained obscure until the 
1990s, when phenazine biosynthesis genes were cloned and sequenced from several 
Pseudomonas species (Pierson et al., 1995; Mavrodi et al., 1998; Mavrodi et al., 2001). 
A conserved seven-gene operon, phzABCDEFG, present in two copies in P. aeruginosa 
(Mavrodi et al., 2001), was implicated in the synthesis of PCA. I refer to these genes as 
the “core phenazine biosynthesis genes”. 
Microbial phenazines are structurally diverse but all share a conserved nitrogen-
containing tricyclic core (Figure 1.1), which is assembled by products of the core 
biosynthesis genes.  The synthesis of the phenazine tricycle starts with the anthranilate-
synthase-like enzyme PhzE and the isochorismatase PhzD together catalyzing the 
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conversion of the chorismic acid to trans-2,3-dihydro-3-hydroxyanthranilic acid 
(DHHA), which is then isomerized to 6-amino-5-oxocyclohex-2-ene-1-carboxylic acid 

















Figure 1.1 Phenazine metabolites and biosynthesis 
(A) Structures of some phenazine compounds produced by Pseudomonas, Streptomyces, and Enterobacter, and (B) biosynthesis of the 
common phenazine precursors PCA and PDC from chorismic acid by products of highly conserved core Phz genes. ADIC, - 2-amino-
2-desoxyisochorismic acid; DHHA - trans-2,3-dihydro-3-hydroxyanthranilic acid; AOCHC - 6-amino-5-oxo-2-cyclohexene-1-
carboxylic acid; HHPDC - hexahydrophenazine-1,6-dicarboxylic acid; PCA - phenazine-1-carboxylic acid; PDC – phenazine-1,6-
dicarboxylic acid. 
PhzG 
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Next, two AOCHC molecules are fused into a tricycle intermediate via the head-
to-tail condensation catalyzed by the small ketosteroid isomerase-like protein PhzA/B. 
The final step of the biosynthesis involves the flavin-dependent oxidation that is 
catalyzed by the FMN-dependent oxidase PhzG and yields phenazine-1-carboxylic acid 
(PCA) in Pseudomonas (Blankenfeldt & Parsons, 2014). In other groups of Phz+ 
bacteria, this step results in the formation of phenazine-1,6-dicarboxylic acid (PDC). The 
last core enzyme, PhzC, is a 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase that 
acts upstream of phenazine biosynthesis to ensure an abundant flow of metabolites into 
the shikimate pathway. In addition to highly conserved core genes, most producers carry 
other phenazine genes that vary in number and biological function depending on the 
species of Phz+ bacteria. These auxiliary genes encode enzymes that covert PCA and 
PDC into species-specific phenazine metabolites such as those shown in Figure 1.1, as 
well as proteins that perform efflux, resistance, and regulatory functions (Mavrodi et al., 
2010). 
1.3 Biological function of phenazine metabolites 
Natural phenazines were originally described as microbial pigments with 
unidentified biological function.  However, studies conducted over the past two decades 
have revealed that these metabolites play an important role in the biology of the 
producing bacteria. Most phenazines are broadly inhibitory to bacteria, fungi, and 
parasites, and some have antitumor activity (Smirnov & Kiprianova, 1990). Structurally 
simple phenazines are produced by beneficial strains of the Pseudomonas fluorescens 
complex and P. chlororaphis on the roots of plants, where they suppress soilborne 
diseases caused by fungal pathogens (Chin-A-Woeng, Bloemberg, & Lugtenberg, 2003). 
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D-alanylgriseoluteic acid, produced by Pantoea agglomerans on apple flowers, 
contributes to the suppression of Erwinia amylovora, which causes fireblight disease of 
apples and pears (Giddens, Houliston, & Mahanty, 2003). The antibiotic activity of 
pyocyanin, a blue phenazine synthesized by Pseudomonas aeruginosa, was known as 
early as in the late 1850s (Fordos, 1860; Gessard, 1882), but more recent studies 
demonstrated that this metabolite enables the producing strains to kill Drosophila 
melanogaster and Caenorhabditis elegans (Mahajan-Miklos et al., 1999; Lau et al., 
2003; Cezairliyan, et al., 2013). Pyocyanin is critical for lung infection by P. aeruginosa 
in mice (Lau et al., 2004), and has been detected at concentrations up to 10-4 M in the 
sputa of patients with cystic fibrosis (Mavrodi, Blankenfeldt, & Thomashow, 2006). 
These and other results suggest that pyocyanin is a host-nonspecific pathogenicity factor. 
In contrast, some phenazines produced by Streptomyces spp. are not cytotoxic in 
eukaryotes and hold promise as anticancer or anti-infective drugs (Laursen & Nielsen, 
2004). 
Much of the biological activity of phenazines is due directly to their redox 
properties (Hassan & Fridovich, 1980; Hassett et al., 1992). Pyocyanin can undergo 
cellular redox-cycling in the presence of oxygen and reducing agents including NADH 
and NADPH, causing the accumulation of toxic superoxide (O2
¯•) and hydrogen peroxide 
(H2O2) (Hassan & Fridovich, 1980). This also raises questions as to how phenazine 
producers protect themselves from phenazine toxicity. In E. coli, two redox-sensing 
global regulators, SoxR and OxyR, control stress responses to superoxide and hydrogen 
peroxide, respectively. P. aeruginosa encodes homologs of both regulators, and while the 
global role of OxyR appears to be preserved, the function of SoxR is reduced exclusively 
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to the control of a small group of genes induced by pyocyanin or the redox-active 
compound paraquat (Dietrich et al., 2008). Most strongly induced by these compounds 
are genes encoding a putative flavin-dependent monooxygenase and components of a 
proton-driven pump, MexGHI-OpmD, that belongs to the resistance-nodulation-division 
(RND) superfamily and is involved in active efflux of pyocyanin (Dietrich et al., 2006). 
Among other mechanisms contributing to PYO resistance in P. aeruginosa are high 
levels of superoxide dismutase and catalase activity (Hassett et al., 1992).  
Though traditionally considered secondary metabolites of no direct benefit to the 
cells that produce them, phenazines synthesized by bacteria in their native habitats clearly 
contribute to competitiveness and long-term survival. Thus, phenazine-producing 
pseudomonads are more competitive and survive longer on the roots of wheat than their 
phenazine-nonproducing mutants (Mazzola et al., 1992), and pyocyanin-deficient 
mutants are less virulent and less competitive than wild-type P. aeruginosa in mouse 
acute and chronic pneumonia infection models (Lau et al., 2004). This phenomenon has 
been attributed to the ability of phenazines to transfer electrons to extracellular substrates, 
(also known as extracellular respiration) and thus contribute to redox homeostasis in the 
species that produce them. Pyocyanin helps to maintain the intracellular redox balance in 
P. aeruginosa by accepting electrons from NADH when other oxidants for respiration 
have become limited, and by stimulating the excretion, and subsequent fermentation 
(bypassing oxidative phosphorylation), of pyruvate during the stationary phase (Price-
Whelan, Dietrich, & Newman, 2007). The reduction of extracellular pyocyanin could be 
particularly beneficial under conditions of oxygen limitation such as those found in the 
biofilms inhabited by P. aeruginosa in chronically-infected host tissues. Consistent with 
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this model, phenazines have been implicated in the anaerobic survival of P. aeruginosa 
(Wang et al., 2010), and Phz- mutants of P. chlororaphis 30-84 were impaired in the 
formation of biofilms in a flow cell system (Maddula et al., 2006). 
Phenazines can also act as electron shuttles to promote microbial mineral 
reduction, and it has been suggested that they could make ferric iron oxides and other 
nutrients in soil more accessible to microorganisms (Price-Whelan, Dietrich, & Newman, 
2007). In microbial fuel cells, which actually select for phenazine-producing strains, 
electron shuttling due to pyocyanin produced by P. aeruginosa markedly stimulated 
growth and power output not only by the producer strain but also by other bacteria in 
mixed communities (Rabaey et al., 2004). Phenazine-1-carboxylic acid produced by P. 
aeruginosa makes iron more bioavailable by reducing Fe(III) to Fe(II), and, together with 
siderophores and heme uptake systems, facilitates the formation of biofilms in iron-
limited environments, such as lungs of CF patients (Wang et al., 2011). 
1.4 Phenazine production in Burkholderia spp. 
The production of phenazines in Burkholderia was first reported in the 1950s-
1970s, when several studies independently reported the isolation of these secondary 
metabolites from strains of Pseudomonas multivorans, Pseudomonas cepacia, and 
Pseudomonas phenazinium (all organisms were later reclassified as members of 
Burkholderia and Paraburkholderia) (Morris & Roberts, 1959; Ballard et al., 1970; Bell 
& Turner, 1973; Korth et al., 1978). Phenazines produced by B. glumae were described 
in a short report published much later (Han et al., 2014). The common theme of all the 
studies mentioned above is that they focused solely on the solvent extraction and 
fractionation of phenazine pigments from wild type strains and their characterization by 
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analytical methods. Several older studies also used isotope probing techniques to unravel 
biochemical details of phenazine biosynthesis (Byng & Turner, 1976; Byng & Turner, 
1977; Korth et al., 1978), but the genetic basis for the production of these versatile 
metabolites in Burkholderia spp. remains unexplored. Several years ago, a study by 
Mavrodi et al. (2010) designed primers and probes targeting the core phenazine 
biosynthesis gene phzF and then applied them to determine the distribution of phz genes 
among environmental and clinical isolates representing five different genera of Gram-
positive and Gram-negative bacteria. Although the authors included in that project 
several phenazine-producing strains of Burkholderia, only two genome sequences of 
Phz+ strains were available for the analysis, which severely limited the scope of the 
study. Hence, the broader picture of the distribution, organization, and evolution of 
phenazine pathways in Burkholderia spp. and closely related taxa remains poorly 
understood. Finally, it is clear that phenazines of Burkholderia have broad-spectrum 
antimicrobial properties and, like their counterparts from pseudomonads, can arrest the 
growth of numerous species of bacteria and fungi (Smirnov & Kiprianova, 1990; 
Cartwright et al., 1995; Han et al., 2014). However, the broader understanding of the 
contribution of phenazine metabolites to the biology of saprophytic and pathogenic 
members of the genus Burkholderia remains unexplored. 
1.5 Aims of this study  
The evolution of phenazine biosynthetic genes in Burkholderia is not well studied, 
though phenazines were first discovered over 150 years ago. Most of our recent 
understanding of the diverse biological functions of phenazines and the effects they exert 
on higher organisms is based on a single model – the opportunistic human pathogen P. 
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aeruginosa. Similar information for other groups of phenazine-producing bacteria is 
missing. My work attempted to address this critical gap in our knowledge by focusing on 
phenazines produced by Burkholderia spp. These organisms are ubiquitous in the 
environment and contain non-pathogenic species, as well as species that cause hospital-
acquired infections and colonize the lungs of individuals with cystic fibrosis. I aimed to 
characterize the diversity, function and biological role of phenazine pathways in B. lata 
ATCC 17760, which belongs to the economically-important Burkholderia cepacia 
complex (Bcc). The specific objectives of my research project were: 
1) To analyze the distribution, organization and evolution of phenazine biosynthesis 
pathways in Burkholderia spp. 
2) To conduct genetic analysis of the phenazine biosynthesis in B. lata ATCC 17760. 







CHAPTER II - MATERIALS AND METHODS 
2.1 Screening the newly-sequenced and publicly-available genome sequences of 
Burkholderia for the presence of phenazine biosynthesis genes. 
Genome sequences of phenazine-producing Burkholderia used in this study were 
acquired from several sources. Implementation of blast searches were used to sift through 
publicly-available repositories of bacteria genomes such as the National Center for 
Biotechnology Information (NCBI) GenBank (Benson et al., 2014), the Joint Genome 
Institute (JGI) Integrated Microbial Genomes and Microbiomes database (IGM/M) 
(Markowitz et al., 2012), and the Burkholderia Genome Database (Winsor et al., 2008).  
Screening was accomplished by using the tblastn algorithm (searching translated 
nucleotide databases using a protein query) with a cut-off E-value < 1e-5.  It has 
previously been described that in phenazine-producing bacteria a small dimeric protein 
PhzA/B catalyzes the symmetrical head-to-tail condensation of two precursor molecules 
and is critical for the formation of the tricyclic phenazine ring (Blankenfeldt & Parsons, 
2014).  The amino acid sequence of PhzA/B from B. lata ATCC 17760 was used as a 
query for searching databases and identifying Burkholderia genomes that harbor a 
phenazine loci.  In addition to the publicly available genomes, draft genomes of three 
strains of phenazine-producing Burkholderia were also sequenced, annotated by the 
Mavrodi research lab and used in bioinformatics analyses.   
Draft genomes were assembled using MiSeq instrument (Illumina, San Diego, 
CA) by the AgriLife Genomics and Bioinformatics Service at Texas A&M University 
(College Station, TX).  Raw reads were filtered using a FastQC toolkit (Andrews, 2010) 
followed by an assembly with the combination of BayesHammer (Nikolenko et al., 2013) 
 
15 
and SPAdes (Bankevich et al., 2012) implemented in the Pathosystems Resource 
Integration Center (PATRIC) (Wattam et al., 2014).  Scaffolds of the final assemblies 
that contained phenazine biosynthesis genes were extracted from genome sequences and 
trimmed using Geneious 10.2.3 (Biomatters, Auckland, New Zealand).   
 Analysis of the diversity and arrangement of the core, modifying, and auxiliary 
genes in phz clusters of different Burkholderia spp. was conducted in Geneious 10.2.3 
using reciprocal BLAST searches and the dotplot sequence comparisons with EMBOSS 
dotmatcher (Rice et al., 2000). The screening of flanking regions of phenazine loci were 
analyzed using the DNA G+C content.  Sequences were screened using tRNAscan-SE 
(Schattner et al., 2005), ISfinder (Kichenaradja et al., 2010), and Island Viewer (Dhillon 
et al., 2015) to identify genomic islands and genes encoding tRNAs, site-specific 
recombinases, and transposases.  Phenazine gene clusters and flanking genomic regions 
were aligned in Geneious using Multiple Alignment using Fast Fourier Transform 
(MAFFT) 7.309 (Katoh & Standley, 2013). 
 The evolution of the phz pathway in Burkholderia was analyzed by establishing 
phylogenies inferred from sequences of core phenazine biosynthesis and housekeeping 
genes. Sequences were concatenated and aligned using MUSCLE (Edgar, 2004), and 
phylogenetic trees were inferred with Geneious Tree Builder using the neighbor joining 
(NJ) algorithm. The DNA and protein distances were corrected, respectively, by 
Kimura’s two-parameter (Kimura, 1980) and Jukes-Cantor (Jukes & Cantor, 1969) 





2.2 Genetic analysis of phenazine biosynthesis in Burkholderia spp. 
Amino acid sequences of PhzA, PhzF, and PhzG (also hypothesized to be 
involved in the formation of PCA or PDC) from B. lata ATCC 17760 were used as blastp 
queries to interrogate the NCBI GenBank and JGI Integrated Microbial Genomes and 
Microbiomes (IMG/M) databases and the resultant hits were used to compare PhzA, 
PhzF, and PhzG of Burkholderia to their counterparts from taxa that are known to 
produce PCA (Pseudomonas and some Streptomyces) or PDC (Burkholderia and some 
Actinobacteria). Comparisons were performed using phylogenetic tools previously 
outlined in section 2.1. The homologs of phenazine modifying enzymes encoded by 
pcm1, pcm2, and pcm3 were determined using blast searches against GenBank and 
IMG/M databases.  The composition, physical properties, and possible cellular 
localization was identified using tools implemented in the European Molecular Biology 
Open Software Suite (EMBOSS) (Rice et al., 2000).  Functional motifs were then 
searched using regular expressions, generalized profiles, and hidden Markov models 
implemented in the MyHits database (http://myhits.isb-sib.ch/), and protein folds were 
predicted using the Phyre2 server (Kelley et al., 2015).   
Plasmid deletion derivatives of the phenazine cluster from B. lata ATCC 17760 
were used to identify phenazine products when certain biosynthetic genes were inactive 
or deleted. The plasmids were generated by amplifying sets of phz genes using PCR with 
high-fidelity KOD Hot Start DNA polymerase (Millipore Sigma) and assembling them in 
the cloning vector pBluescript II KS (+) (Stratagene).  The cloned amplicons were single-
pass sequenced to ensure the absence of unwanted mutations and sub-cloned into broad 
host range plasmid vectors pUCP26 (West et al., 1994) and pBBR1MCS (Kovach et al., 
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1994) under the control of lac promoter. The pUCP26-based plasmids were introduced 
for heterologous expression into the phenazine-deficient mutant strain Pseudomonas 
fluorescens 2-79Z (Khan et al., 2005), while the pBBR1MCS-based constructs were used 
in experiments with B. lata ATCC 17760. In addition, my experiments employed 
phenazine-nonproducing isogenic mutants of ATCC 17760 that were constructed by 
interrupting genes phzA, pcm1, and pcm3 with the insertion of the p34S-Tp trimethoprim-
resistance cassette (Dennis & Zylstra, 1998). The 2-79Z and ATCC 17760 derivatives 
carrying appropriate plasmids were generated by electroporation, selected by plating on 
LB agar supplemented with tetracycline or trimethoprim, and confirmed by PCR with 
plasmid-specific primers. The cultures were shipped to the Dr. Wulf Blankenfeldt’s lab at 
the Helmholtz Centre for Infection Research in Braunschweig, Germany, where 
phenazine intermediates produced by plasmid deletion derivatives and isogenic mutants 
were extracted and analyzed by HPLC-coupled mass-spectrometry and NMR. 
2.3 Pathogenicity assays with the fruit fly Drosophila melanogaster and onions 
Using an assay of Castonguay-Vanier et al., I evaluated the contribution of 
phenazine metabolites to the virulence of Burkholderia (Castonguay-Vanier et al., 2010), 
by using the fruit fly Drosophila melanogaster as a surrogate host for pathogenic 
members of the Bcc group. Briefly, bacterial cultures were grown in Tryptic Soy Broth to 
an optical density (OD600) of 2. Cells were then washed with sterile 10 mM MgSO4, 
suspended in the same buffer, and adjusted by serial dilution to the desired concentration. 
Ampicillin (500 mg/mL) was added to the cell suspensions to prevent possible infection 
with bacteria present on the surface of the fly. Adult flies of 8 ± 2 days were anesthetized 
with CO2 and pricked in the dorsal thorax using a 27-gauge syringe needle previously 
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dipped in the appropriate bacterial cell suspension. Control flies were pricked with a 
needle dipped into a solution of 10 mM MgSO4 supplemented with ampicillin. The 
inoculated flies were maintained at 25°C and scored daily for survival. The infection 
assays were performed with a minimum of 30 flies for each strain, and all experiments 
were repeated in multiple repetitions.  
The impact of phenazines on tissue infection in onions was modeled using 
methods from Jacobs et al. (2008). Onions were quartered using a sharp, sterile blade, 
and the quartered sections were separated into individual layers. Overnight cultures of 
Burkholderia spp. grown in TSB were adjusted to 107 CFU/mL, and 5-mL aliquots of 
bacterial suspensions were injected into onion slices using a sterile 10 mL pipette tip. The 
inoculated slices were incubated at 30°C on water-saturated filter paper placed in Petri 
plates. The degree of tissue maceration was scored after 40 hrs on a scale of 0-3 (0, no 
visible maceration; 1, < 33% maceration; 2, 34-65% maceration; 3, 66-100% 
maceration). B. cepacia ATCC 25416 is an onion pathogen and was used as a positive 
control. The negative control was inoculated with 5 ml of TSB. The experiment was 
repeated twice with five replicates of each treatment. 
2.4 Flow cell and static biofilm assays 
The effect of phenazines on biofilm formation was examined in B. lata ATCC 
17760 and its phenazine-deficient isogenic mutant B. lata phzA and overproducing 
derivative carrying the pBBR1-MCS-all plasmid. The bacteria were cultured overnight at 
27°C on one-third-strength King’s Medium B (1/3 KMB) plates, then scraped off the 
surface of the agar and suspended in 1/3 KMB broth at a density of approximately 108 
CFU/mL. The standardized bacterial suspensions were inoculated into a 24-well two 
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inlets-one outlet flow cell plate, was connected to a BioFlux 200 microfluidistic system 
(Fluxion Biosciences). The inoculum was first pumped into the flow cell at 1.0 dyn/cm2 
for 6 sec, and bacteria were then allowed to attach to the channel surface for 1 h at 27°C. 
Initially, a flow rate of 0.16 dyn/cm2 for the first 12-14 h, and after that, a flow rate of 
0.44 dyn/cm2 was set for 36 h to continuously pump fresh 1/3 KMB through channels 
containing bacteria. The development of biofilms was monitored by collecting bright-
field images every 20 min with an LS620 digital microscope (Etaluma). The acquired 
images were merged into a time-lapse movie using BioFlux software (Fluxion 
Biosciences). The images were also normalized using the Threshold and Slider tools of 
the BioFlux Montage software (Fluxion) and used to quantify the biofilm growth by 
calculating total percentage of area covered by the biofilm and plotting it against the time 
frames. 
The ability of B. lata ATCC 17760 and its mutants to form static biofilms was 
determined using the crystal violet biofilm assay developed by O’Toole (2011). Briefly, 
cultures were grown on LB plates supplemented with appropriate antibiotics for 24 h, 
bacteria were scraped off the agar, and OD600 was adjusted to 0.1. The normalized 
suspensions were diluted 1:100 in KMB broth and 100 µL aliquots were dispensed into 
96-well U-bottom PVC microplates (Costar). The inoculated microplates were incubated 
for 48 h at 27°C, after which all wells were gently rinsed with water to remove the 
unattached cells and media components. Crystal violet (0.1%) was added to each well 
and after 15 min of staining the microplates were rinsed, dried, and the retained dye was 
solubilized with 30% acetic acid. The amount of the retained dye was quantified by 
measuring absorbance at 550 nm. The experiments were repeated four times with 60 
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replicates per strain, and differences between treatments were assessed by Kruskal-Wallis 




CHAPTER III – RESULTS 
3.1 Screening Burkholderia genomes for the presence of phenazine genes 
Screening of publicly accessible databases yielded multiple genome sequences of 
Burkholderia capable of producing phenazines. Overall, phenazine gene clusters were 
identified in 20 strains of Burkholderia and in one strain of Paraburkholderia that have a 
worldwide origin and belong to different species of the two genera. According to 
GenBank records, most of these genomes came from strains isolated from samples of soil 
collected in the Northern Territory of Australia and were sequenced during a single 
project by the Northern Arizona University. Two more Australian strains (BDU5 and 
BDU6) were isolated from soil on Badu Island located in the Torres Strait, and another 
one (TSV 85) from water collected in Townsville, Queensland. Both genomes of B. 
glumae (BGR1 and LMG 2196) belonged to phenazine-producing strains isolated from 
rice in Japan (Urakami et al., 1994; Jeong et al., 2003), whereas B. lata ATCC 17760 
originated from soil collected in Trinidad (Stanier, Palleroni, & Doudoroff, 1966). In 
addition to publicly available genomes, we sequenced and annotated draft genome 
sequences of three strains of Phz+ Burkholderia. Two of these strains, Burkholderia sp. 
2424 and PC17, were isolated in Japan from the rhizosphere of Welsh onion (Seo & 
Tsuchiya, 2004). The third strain, Burkholderia sp. 5.5B, is a soil isolate and biological 
control agent from USA (Cartwright et al., 1995). Finally, in the Paraburkholderia 
group, phenazine genes were present in just one strain, the soil isolate P. phenazinium 
LMG 2247 (Bell & Turner, 1973). Phylograms inferred from 16S rRNA sequences of 
Phz+ strains and type strains revealed that most phenazine-producing Burkholderia were 





Figure 3.1 16s rRNA phylogeny of Burkholderia spp. 
Distribution of phenazine biosynthesis genes among different lineages of Burkholderia, Paraburkholderia, and Caballeronia. The 
neighbor-joining phylogeny was established based on 16S rRNA sequences, with Ralstonia solanacearum LMG 2299T used as an 
outgroup. Confirmed phenazine-producing strains are highlighted in bold font. Sequences were aligned in Geneious 10.2.3 with 
MAFFT 7.309 (37). Indels were ignored, and the final alignment used for analysis contained 1,314 positions. Evolutionary distances 
were estimated using the Kimura two-parameter model of nucleotide substitution. Gray circles on the tree nodes indicate bootstrap 
values that vary between 50.0% (smallest circle) and 100% (largest circles). The final tree was visualized in iTOL (43). Values in 
brackets indicate GenBank accession numbers. 
 
present in the plant pathogen B. glumae, and some strains of the B. pseudomallei clade. 
Although the phylogeny was overall robust, the high degree of conservation of 16S rRNA 
sequences did not allow to assign strains BDU5 and TSV 85 any clade of Burkholderia 
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spp. To increase the resolution of this analysis, we repeated it with seven housekeeping 
genes employed in the Multilocus Sequence Typing (MLST) of the Bcc group (Spilker et 
al., 2009) (Figure 3.2). 
 
 
Figure 3.2 Multi-locus sequence typing phylogeny of Burkholderia spp. 
Neighbor-joining phylogeny inferred from concatenated protein sequences (4,458 characters) of housekeeping enzymes AtpD, GltB, 
GyrB, RecA, LepA, PhaC, and TrpB. Sequences from P. phenazinium LMG 2247T were used as an outgroup. Strains carrying 
phenazine biosynthesis genes are highlighted in bold font. Indels were ignored in the analysis, and evolutionary distances were 
estimated using the Jukes-Cantor genetic distance model. The reproducibility of clades was assessed by bootstrap resampling with 
1,000 pseudoreplicates, and bootstrap values greater than 60% are indicated by gray circles at the nodes (circle sizes are proportional 




The dataset included concatenated amino sequences of the products of atpD (ATP 
synthase beta chain), gltB (glutamate synthase large subunit), gyrB (DNA gyrase subunit 
B), recA (recombinase A), lepA (GTP binding protein), phaC (acetoacetyl-CoA 
reductase), and trpB (tryptophan synthase subunit B). The resultant well-resolved 
phylogeny agreed with the16S rRNA gene analysis, and also unambiguously identified 
strains BDU5, BDU6, and TSV 85 as members of the P. pseudomallei clade (Figure 3.2). 
The MLST-based phylogeny also confirmed that most Phz+ strains of the Bcc clade were 
closely related to the primary species of the genus, B. cepacia, and revealed that other 




Figure 3.3 Contrasting phylogenies using phz proteins and housekeeping enzymes 
In some species of Burkholderia phenazine genes may have been acquired via horizontal gene transfer. Contrasting neighbor-joining 
phylogenies inferred from concatenated sequences of PhzA/B, PhzE, and PhzG proteins (A) and housekeeping enzymes AtpD, GltB, 
GyrB, RecA, LepA, PhaC, and TrpB (B). Indels were ignored in the analysis, and the concatenated Phz and housekeeping data sets 
contained 1,024 and 4,458 characters, respectively. Sequences from P. phenazinium LMG 2247T were used as an outgroup. 
Evolutionary distances were estimated using the Jukes-Cantor genetic distance model. The reproducibility of clades was assessed by 
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bootstrap resampling with 1,000 pseudoreplicates, and bootstrap values greater than 60% are indicated by grey circles at the nodes 
(circle sizes are proportional to bootstrap values). The branch lengths are proportional to the amount of evolutionary change, and the 
scale bars indicate substitution per site. 
 
Finally, we attempted to gain insight in the evolutionary trajectory of phenazine genes by 
contrasting the phylogeny of concatenated sequences of PhzA/B, PhzE, and PhzG 
proteins to that of the core Burkholderia genome estimated using seven conserved 
housekeeping genes. This analysis produced phylogenetic trees with mostly congruent 
topologies (Figure 3.3). One notable exception was discovered in strains B. ubonensis 
MSMB 2058 and B. ubonensis MSMB 2035, which are members of the Bcc group, but 
harbor phenazine biosynthesis genes that are close to those from B. singularis TSV 85, 
which belongs to the P. pseudomallei clade. Also, the core phenazine genes of BGR1 and 
LMG 2196 clustered tightly within the Bcc clade, although both strains are members of 
the distinct B. glumae/B. gladioli clade. 
 
 
Figure 3.4 Gene organization of various Burkholderia phz loci 
Comparison of the phenazine gene cluster of B. lata ATCC 17760 to its counterparts from other Burkholderia and P. phenazinium, 
and to the esmeraldin biosynthesis (esm) locus of Streptomyces antibioticus Tu2706. Homologous genes are indicated by arrows of the 
same color and connected with shading, whereas unique species-specific genes are shown by open arrows. The arrows with bold 
outlines indicate known or putative phenazine transport genes. The sizes of genes and intergenic regions are not to scale. Locus tags 




We also compared the overall organization and diversity of the phenazine pathways in 
Burkholderia spp. A comparison of genome sequences revealed the presence of three 
distinct types of phenazine cluster (Figure 3.4). The first type is represented by a nine-
gene operon found in B. lata ATCC 17760, most strains of the Bcc group, and B. glumae. 
The second type was discovered in strains BDU5 and BDU6, where the DNA segment 
encoding the phzC and pcm3 genes is flipped. The third type of the phenazine locus was 
identified in B. ubonensis strains MSMB 2058 and MSMB 2035 and in B. singularis 
TSV 85. These strains shared an 18-gene phenazine cluster that was very different from 
its counterparts in other Burkholderia and closely resembled genes involved in the 
synthesis of phenazine esmeraldin from Streptomyces antibioticus (Rui et al., 2012). 
Interestingly, in B. ubonensis MSMB 2035, the phenazine locus is encoded by a 
conjugative plasmid pMSMB 2013 (GenBank acc. no. NZ_CP013415) that forms part of 
this strain’s genome. The production of phenazine appears to be a lot less common in the 
closely related genus Paraburkholderia, and my analysis identified only one Phz+ 
member of this group, P. phenazinium. The chromosome-encoded phz cluster of this 
strains is distinct from its counterparts present in genomes of Burkholderia spp. Finally, 
we also compared the genome regions flanking the phenazine genes in different strains of 
Burkholderia. This analysis revealed that in members of the Bcc group, the phz clusters 
are highly conserved but embedded in different spots of the genome, often adjacent to 







Figure 3.5 Flanking regions surrounding the phz loci 
Synteny of genomic regions carrying genes involved in the synthesis of phenazines in selected strains of Burkholderia. DNA 
sequences were aligned in Geneious 10.2.3 using MAFFT 7.309 with default parameters. Predicted genes and their orientation are 
shown by horizontal arrows with phz genes highlighted in red and homologous flanking genes indicated by different colors. All genes 
and intergenic regions are drawn to scale, as indicated by the scale bar in the upper right corner. 
 
3.2 Genetic analysis of phenazine biosynthesis in B. lata ATCC 17760 
The project was initiated by analyzing the spectrum of metabolites produced in 
strains carrying the full complement of phenazine biosynthesis genes of B. lata. The 
analysis of fractionated organic solvent extracts from the wild-type strain B. lata ATCC 
17760, its complemented mutant B. lata phzA/pBBR1MCS-all, and P. fluorescens 2-79Z 
carrying a complete set of phz genes on the plasmid pUCP26-all identified 4,9-
dihydroxyphenazine-1,6-dicarboxylic acid dimethylester as the final product of the 
pathway and revealed the presence of multiple phenazine intermediates (Figure 3.6). The 
synthesis of phenazines in B. lata was strongly affected by the growth conditions, and 
best yields were observed in cultures grown in King’s medium B (King et al., 1954). The 
levels of different phenazine derivatives were very dynamic (especially in the 
overproducer B. lata phzA/pBBR1-MCS-all) and may reflect an inherent feature of the 
regulation of phz genes in Burkholderia spp. All identified phenazine derivatives had 
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close retention times (7-12 min) on the Acquity UPLC BEH C18
 column (502.1mm, 
diameter of BEH particles 1.7 μm) (Waters) and were therefore difficult to separate. In 
total, six phenazine compounds (①, ②, ③, ⑤, ⑦ and ⑧, where ① = ⑤) were 
detected, four of which were purified and characterized in detail by NMR. Two other 
phenazine compounds (③ and ⑧) could not be isolated in sufficient quantities and were 
identified based on their HPLC-UV-MS profiles. In addition, one more metabolite (⑥) 
was provisionally identified as a phenazine derivative, but more data is needed to confirm 
its structure. The analysis also identified three non-phenazine compounds, ⑨, ⑩, and 
⑪, that were produced by the wild-type B. lata but absent from its phenazine-deficient 
mutants phzA and pcm1. The analysis of isogenic mutants of B. lata revealed that the 
interruption of phzA, pcm1 and pcm3 genes abolishes the production of all phenazines, 
which coincides with the loss of purple pigmentation (Figure 3.7). Probing derivatives of 
P. synxantha 2-79Z carrying different plasmid deletion variants of the phz locus by 
HPLC-MS correlated the presence pcm1 and pcm2 genes with modifications of 
phenazine-1,6-dicarboxylic acid (PDC), which is the product of the core part of the 
pathway in B. lata. Specifically, pcm2 was associated with the methylation of carboxyl 
moieties in positions 1 and 6, while pcm1 was required for the hydroxylation of 
phenazine ring on positions 4 and 9. Subsequent protein structure predictions with Phyre2 
supported these observations and identified the products of Pcm1 and Pcm2 as a flavin 
monooxygenase and SAM-dependent methyltransferase, respectively. The product of the 
third putative modifying gene, pcm3, was identified as a NAD(P)H-dependent 
oxidoreductase, but its exact role in the conversion of PDC to 4,9-dihydroxyphenazine-













Figure 3.6 Phenazine intermediates identified from culture of B. lata ATCC 17760 
 (A) Phenazine intermediates and other secondary metabolites identified in extracts of B. lata ATCC 17760 (A), and (B) comparison 
of phenazines produced by B. lata and P. fluorescens 2-79Z carrying the pUCP26-all plasmid. All phenazine derivatives are shown in 
blue, while the non-phenazine compounds are shown in green. Intermediates ③ and ⑧ could not be purified and were identified 




Figure 3.7 Genetic organization of phz gene cluster in B. lata ATCC 17760 
(A) Genetic organization of the phz gene cluster from B. lata ATCC 17760, isogenic mutants, and pUCP26-based deletion plasmids 
used in this study. Predicted genes are shown by colored arrows. DNA fragments contained in plasmids used in this study are 
indicated by thick lines.   , insertions of the Tpr cassette in the genome of B. lata;      , positions of the lac promoter from pUCP26. The 
right panel depicts structures of phenazines detected in P. synxantha 2-79Z carrying different deletion plasmids by HPLC-coupled 
ESI-MS. (B) The proposed role of enzymes encoded by pcm1 and pcm2 in the biosynthesis of 4,9-dihydrophenazine-1,6-dicarboxylic 
acid dimethylester. (C) The the appearance of wild-type B. lata ATCC17760 and its phzA mutant in King’s medium B. 
 
3.3 Biological function of phenazine compounds in B. lata ATCC 17760 
The analysis of the possible role of phenazines in the virulence of Burkholderia 
involved two sets of experiments. First, different phenazine-producing and non-
producing strains were compared for the capacity to kill fruit flies in the pricking assay of 
Castonguay-Vanier et al. (2010). Results of these assays revealed that Burkholderia 
readily infect and kill D. melanogaster (Figure 3.8). With the exception of less virulent 
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Figure 3.8 Survival curves for D. melanogaster infected with Burkholderia spp. 
Pricking assays were performed with inocula adjusted to 108 CFU mL-1. Flies in the uninoculated control were pricked with a needle 
dipped in 10 mM MgSO4. *Significantly different (according to the Kaplan-Meier log-rank test at P ≤ 0.05) from the positive control 
ATCC 25416. The experiment was conducted twice with similar results. 
 
B. ambifaria, all tested wild type strains were lethal to flies and killed all inoculated 
animals within 40 hrs. In contrast, the survival of the uninoculated control (10 mM 
MgSO4) was over 86 % (Figure 3.8). The virulence did not appear to correlate with the 
presence of phz genes, as phenazine-nonproducing B. cepacia ATCC 25416 killed flies 
on a par with its phenazine-producing (ATCC 17760, PC17, PC39, 2424) and 
overproducing (phzA/pBBR1MCS-all) counterparts. In the second series of experiments, 
an attempt was made to slow the rate of killing by lowering the concentration of bacteria 
used to inoculate fruit flies. Since most Burkholderia were highly virulent toward D. 
melanogaster, the concentration of inoculum was optimized in a dose-response 
experiment, where flies were inoculated with suspensions of B. cepacia ATCC 25416 and 
B. lata ATCC 17760 adjusted to 107, 106, and 105 CFU mL-1. Results of these assays 
revealed that lower infection dose resulted in better survival of fruit flies, which at 105 
CFU mL-1 approached 80 % (Table 3.1). 
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Table 3.1. Dose-response assays with B. cepacia ATCC 25416 and B. lata ATCC 17760. 
*Significantly different from the inoculum level of 107 CFU mL-1 (P ≤ 0.05). The experiment was conducted twice with similar 
results. 
 
The third round of experiments compared the virulence of the wild-type parental 
strain B. lata ATCC 17760, its isogenic mutants phzA, pcm1, and pcm3, and the 
phenazine-overproducing variant harboring the plasmid pBBR1MCS-all. The strains 
were applied at two inoculum levels: high (107 CFU mL-1) and low (105 CFU mL-1) 
(Table 3.2). The side-by-side comparison of ATCC 17760 and its phenazine-deficient 
and -overproducing derivatives showed no statistically significant difference between 
treatments thus suggesting against the involvement of phenazines in the virulence 






Treatment Inoculum (CFU mL-1) % survival P value 
B. cepacia ATCC 25416 107  25.0 - 
 106 55.0 0.1370 
 105 80.0 0.0017* 
B. lata ATCC 17760 107  20.0 - 
 106 60.0 0.0067 
 105 80.0 0.0012* 
 
33 
Table 3.2. Fruit fly pathogenicity assays with B. lata ATCC 17760 and its isogenic 
phenazine mutant derivatives. 
a Percent survival after seven days. b Comparison to the wild-type control strain using the Kaplan-Meier log-rank test. The experiments 
were repeated with similar results. 
 
The four phenazine-producing and two nonproducing strains of Burkhoderia were 
also compared for their capacity to invade plant tissues and cause maceration of onion 
bulbs. The Phz- B. cepacia ATCC 25416 is a postharvest onion pathogen and was 
included as a positive control. Results of these assays separated the tested strains into two 
groups that exhibited, respectively, the high (ATCC 25416, PC39, PC17, 2424) and low 
(ATCC 17760 and AMMD) capacity to infect and damage onion bulbs (Table 3.3, Figure 
3.9). However, as in the case fruit fly assays, no correlation was observed between the 





Inoculated at 107 CFU 
mL-1  
Inoculated at 105 CFU 
mL-1 
% survival a P value b % survival a P value b 
ATCC17760 (wild type 
control) 
3.3 
- 76.7 - 
phzA 26.7 0.8933 86.7 0.3193 
pcm1 20.0 0.8435 86.7 0.3611              
pcm3 20.0 0.2495 73.3 0.1296 




Table 3.3. Onion tissue maceration assays with different Burkholderia spp. 
Strain 
Onion maceration score 
Experiment 1 Experiment 2 
B. cepacia ATCC 25416 (Phz-) 2.3  1.1 A 2.4  0.8 AB 
B. ambifaria AMMD (Phz-) 0.4  0.5 B 0.8  0.5 C 
B. lata ATCC 17760 (Phz+) 0.4  0.5 B 0.8  0.5 C 
Burkholderia sp. PC17 (Phz+) 2.2  0.8 A 2.6  0.5 A 
Burkholderia sp. PC39 (Phz+) 1.6  0.9 A 1.8  0.8 AB 
Burkholderia sp. 2424 (Phz+) 1.6  1.1 A 1.6  0.9 BC 
Onion tissue damage was scored on a scale of 0-3 (0, no visible maceration; 1, < 33% maceration; 2, 34-65% maceration; 3, 66-100% 
maceration). ATCC 25416 is an onion pathogen and was used as a positive control, and the negative control was inoculated with TSB. 
The experiment was conducted twice with five replicates per treatment. Mean comparisons among treatments were performed with 
Fisher’s protected LSD test (P ≤ 0.05).  
Figure 3.9 Onion tissue maceration by B. cepacia ATCC 25416  
The appearance of onion bulb tissue after inoculation with B. cepacia ATCC 25416 (positive control) (A) or Tryptic Soy Broth 





In fluorescent Pseudomonas, the formation of biofilms and their morphology is 
affected by the presence and nature of phenazine compounds. Many species of the B. 
cepacia complex are known for their capacity to form extensive biofilms, which 
prompted us to test the possible link between the synthesis of phenazines and formation 
of biofilms in B. lata. The biofilm assays compared the wild-type strain ATCC 17760, its 
phenazine-deficient phzA mutant, and the complemented mutant phzA(pBBR1MCS-all), 
which overproduces phenazines. The bacteria were inoculated in a flow cell connected to 
a BioFlux 200 microfluidistic system and cultured in a medium conducive for the 
production of phenazines, King’s medium B. The development of biofilms was 
monitored over 48 h by acquiring bright field micrographs and subsequently analyzing 
them in the BioFlux Montage software. Results of these experiments revealed distinct 
differences in the dynamics of the establishment and development of biofilms in the three 
tested strains. In particular, the wild-type and overproducer strains attached faster and 
formed thicker biofilms than the phzA mutant (Figure 3.10). Interestingly, the phenazine- 
overproducing variant formed the densest biofilms that also did not slough off in the 
medium flow, whereas mature biofilms of the wild-type strain readily dispersed. A 
similar trend was observed in static biofilm assays performed with the wild type B. lata 
strain and its phenazine-deficient and complemented derivatives (Figure 3.11). The 
crystal violet staining of biofilms formed in PVC plates revealed that ATCC 17760 and 
phzA(pBBR1MCS-all) bound significantly more dye (P < 0.05 by Kruskal Wallis rank 
sum and Dunn tests) than the phzA, pcm1, and pcm3 mutants. The most robust biofilm 
was observed in the complemented phzA mutant, thus mirroring the results obtained in 




Figure 3.10 Graph of % coverage of biofilm in BioFlux microfluidistic system 
Continuous monitoring of biofilm formation by B. lata ATCC 17760, its phenazine-deficient phzA mutant, and the phenazine-
overproducing derivative phzA(pBBR1MCS-all). The three stains were inoculated into the BioFlux microfluidic system and allowed 
to form a biofilm for 48 h. The bright-field images were collected at 20 min intervals with a LS620 digital microscope. The top panel 
indicates the surface area covered by the growing biofilm, whereas the bottom panel shows representative images of biofilm 













Figure 3.11 Static biofilm formation 
Static biofilms formed by B. lata ATCC 17760 and its phenazine-deficient and complemented derivatives. All strains were inoculated 
at approximately 106 CFU mL-1 and grown in 96-well PVC plates for 48 h, at which point the biofilms were stained with crystal 
violet. Bars with different letters indicate significant differences as determined by the Kruskal-Wallis rank test followed by Dunn’s 
multiple comparisons test (P < 0.05). 
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CHAPTER IV – DISCUSSION 
To the best of our knowledge, this is the first study that attempted to 
comprehensively address the genetics, evolution, and biological role of phenazine 
compounds in Burkholderia. Although the production of phenazines in this 
economically-important group of microorganisms was first reported almost 70 years ago 
(Turner & Messenger, 1986), the access to recently generated genome sequences allowed 
us for the first time to assess the distribution, organization of biosynthesis gene clusters, 
and habitats that support in this versatile and economically important group of phenazine-
producing bacteria. Our results revealed that phz genes are present in genomes of many 
Burkholderia that have a worldwide origin and belong to different species of the genus. 
Most Phz+ strains were in the Bcc group, but the capacity to synthesize phenazines was 
also found in some isolates of the B. pseudomallei clade and the plant pathogen B. 
glumae. Within the Bcc group, most phenazine producers clustered closely with B. 
cepacia thus agreeing with the findings of Mavrodi et al. (2010), who identified several 
strains of Phz+ Burkholderia from Japan as B. cepacia based on amplicon sequences of 
phzF, 16S rRNA, and recA. We also confirmed the presence of phz genes in B. lata 
(ATCC 17760), B. pyrrocinia (strain 5.5B), and identified the first phenazine-producing 
strains of B. ubonensis (MSMSB 2035 and MSMB 2058). Outside of the Bcc complex, 
we discovered the first gene clusters in members of the P. pseudomallei group, including 
B. singularis TSV85 and two strains, BDU5 and BDU6, that did not align closely with 
type strains and may represent new species of this clade. Finally, we confirmed the 
presence of phz genes in genomes of plant-pathogenic B. glumae.  
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Most of the phenazine producers studied in this work were isolated from the 
environment, namely soil, but some originated from diseased plants. Although listed as 
saprophytes, many strains of Phz+ Burkholderia were closely related to species that are 
known to enclose numerous genetically close environmental and clinical isolates. 
Furthermore, several Phz+ strains belonged to P. pseudomallei and B. glumae groups that 
encompass serious pathogens of humans and animals, and crop plants (Eberl & 
Vandamme, 2016). Interestingly, phenazine production seems to be a common trait in B. 
glumae since a study of strains native to the southern United States identified several 
virulent isolates that produced different pigments, one of which was later identified as the 
phenazine phencomycin (Karki et al., 2012; Han et al., 2014). Therefore, the question of 
the association of phenazine production with the saprophytic and parasitic lifestyles of 
Burkholderia spp. clearly deserves further investigation. 
While conducting this study, we were surprised to discover that the majority of 
Phz+ Burkholderia with sequenced genomes were isolated in Australia. It is plausible 
that this prevalence of Australian strains simply reflects a non-random sampling since 
Phz+ Burkholderia were previously isolated in the US (Karki et al., 2012; Cartwright et 
al., 1995), Japan (Seo & Tsuchiya, 2004), Europe (Smirnov & Kiprianova, 1990), and 
other parts of the world (Stanier, Palleroni, & Doudoroff, 1966). Alternatively, it is 
possible that phenazine-producing strains of Burkholderia are more common in specific 
locations, similar to some groups of Phz+ pseudomonads that are enriched in arid soils of 
the US Pacific Northwest (Mavrodi et al., 2012a; Parejko et al., 2012) and Fusarium 
wilt-suppressive soils of Chateaurenard, France (Mazurier et al., 2009). Mavrodi et al. 
(2012) further demonstrated the involvement of these bacteria in the suppression of 
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Rhizoctonia root rot disease and the presence of nanomolar levels of phenazine 
antibiotics in the rhizosphere of field-grown wheat. Further studies also revealed the 
strong impact of irrigation and precipitation on indigenous populations of phenazine-
producing Pseudomonas in dryland wheat fields of central Washington and Oregon 
(Mavrodi et al., 2012b; Mavrodi et al., 2018). It is tempting to speculate that combination 
of environmental and edaphic factors may result in the enrichment of Phz+ Burkholderia 
in certain parts of the world, although further research is needed to confirm or reject this 
hypothesis. 
Our study revealed at least three distinct variants of phenazine clusters in 
phenazine-producing Burkholderia. Most Phz+ species of the B. cepacia and B. glumae 
clades shared an operon comprised of six core and three modifying biosynthesis genes. A 
variation of this scheme was observed in strains BDU5 and BDU6, which had a gene 
cluster with an inverted DNA segment containing the phzC and pcm3 genes. Very 
different phenazine pathways were identified B. singularis TSV 85 and B. ubonensis 
MSMSB 2035 and MSMB 2058. The phz clusters in these species had 18 genes, some of 
which encoded modifying enzymes similar to those involved in the synthesis of 
esmeraldin in S. antibioticus (Rui et al., 2012). Another distinct phenazine cluster was 
discovered in P. phenazinium, which differed from its Burkholderia counterparts in the 
number of core and modifying genes. Overall, these pathways differed in the number and 
types of predicted phenazine-modifying and efflux genes. All Phz+ Burkholderia also 
contained a full complement of core biosynthesis genes, although their arrangement and 
even structure varied between species of phenazine producers. In particular, genomes of 
TSV 85, MSMSB 2035, and MSMB 2058 encoded a Pseudomonas-like version of PhzF 
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that lacked the 120-amino acid N-terminal domain, which is present in homologous 
proteins of other Burkholderia spp. These strains also carried an unusually long version 
of the isochorismatase PhzD, which represents a fusion of the S-adenosylmethionine-
dependent methyltransferase and isochorismate hydrolase domains. Finally, the phz 
clusters of TSV 85, MSMSB 2035, and MSMB 2058 lacked the phzC gene, but at the 
same time carried a gene encoding a canonical 3-deoxy-7-phosphoheptulonate synthase. 
We hypothesize that this enzyme compensates for the lack of PhzC and aids the synthesis 
of phenazines by provides metabolic precursors for the shikimic acid pathway. Our 
results also revealed the conservation of phz clusters in most species of the Bcc group, as 
well the evidence for horizontal gene transfer in B. glumae and strains TSV 85, MSMSB 
2035, and MSMB 2058, which harbor phenazine genes on conjugative plasmids. 
Although structurally conserved, the phenazine operons of Bcc strains are located in 
different genomic regions, which is likely a result of genomic relocation. Collectively 
these findings suggest that phenazine biosynthetic pathway of Burkholderia resembles its 
counterpart from Pseudomonas (Fitzpatrick, 2009; Mavrodi et al., 2010; Biessy et al., 
2018) in that it has a complex evolutionary history, which likely involved horizontal gene 
transfers among several distantly related groups of producing organisms.  
Although structures of some phenazines produced by Burkholderia spp. were 
elucidated several decades ago, the genetic basis for this process remained unexplored. 
Our experiments with B. lata ATCC 17760 represent the first formal confirmation of the 
involvement of the phz cluster in the production of 4,9-dihydroxyphenazine-1,6-
dicarboxylic acid dimethylester. Furthermore, our assays with plasmid deletion 
derivatives provide the first experimental evidence for the role that the three pcm genes 
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play in the modification of the phenazine tricycle during the synthesis of 4,9-
dihydroxyphenazine-1,6-dicarboxylic acid dimethylester. Overall, our results agree with 
the findings of Korth et al. (1978) and indicate the production of phenazine in Bcc strains 
is a highly dynamic process. The presence of multiple intermediates probably reflects the 
symmetrical nature of the final phenazine product, which is assembled via sequential 
hydroxylation and methylation of the PDC precursor. The dynamic nature and yield of 
different phenazine derivatives suggest the complex effect of environment and specific 
and global regulation, details of which remain entirely unknown. 
Earlier studies reported the broad antibiotic activity of phenazines produced by 
several species of the genus Burkholderia (Smirnov & Kiprianova, 1990; Cartwright et 
al., 1995; Han et al., 2014). However, recent studies in P. aeruginosa prompted us to 
probe the broader biological role of phenazines in this diverse group of bacteria. 
Although we failed to correlate the production of phenazines with the capacity of Phz+ 
Burkholderia to kill fruit flies and rot onions, other experiments revealed a link between 
the presence and amount of phenazines and the dynamics of biofilm growth flow in both 
the flow cell and static experimental systems. These preliminary findings suggest that 
Burkholderia, like fluorescent pseudomonads, may benefit from the unique redox-cycling 
properties of phenazines and their capacity to act as extracellular electron shuttles in 
biofilms. These findings also suggest that the contribution of phenazines to the 
pathogenicity of Phz+ members of the Bcc group should be revisited using chronic 
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